Fulvestrant Sandoz 250 mg/5 ml, Injektionslösung in einer Fertigspritze

7680656510028 CH-65651 Injektionslösung
Fulvestrant Sandoz 250 mg/5 ml, Injektionslösung in einer Fertigspritze
Fulvestrant Sandoz 250 mg/5 ml, Injektionslösung in einer Fertigspritze
1 / 2
Fiches Amavita / Sun Store / Coop Vitality

Article details

Package size
2
Selling units
2
Measure
Fertigspritze(n)
Galenic form
Injektionslösung
Galenic group
Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
13/09/2024
Summary of Product Characteristics
Français
13/09/2024
Summary of Product Characteristics
Italien
13/09/2024

Detailed composition

Substance Quantity Type Category
fulvestrantum
250.0 MG Substance Wirkstoff (Principe actif)
ethanolum 96 per centum
500.0 MG Substance HBESI
alcohol benzylicus
500.0 MG Substance HBESI
benzylis benzoas
750.0 MG Substance HBESI
ricini oleum virginale
- Substance HNIDK
ethanolum
12.7 PVV Substance HBESI

Reimbursement information

Public price
CHF 329.05
Specialties list
Yes
Generic
Yes

Reimbursement limitation

SL addition date: 01/08/2016

Authorization holder

Sandoz Pharmaceuticals AG

6343 Risch

Authorization information

Swissmedic authorization number
65651
Drug name
Fulvestrant Sandoz, Injektionslösung in einer Fertigspritze
Galenic form
INLFS
ATC Code
L02BA03
Authorization status
Z
Dispensing category
B
First authorization
23/10/2015
Authorization expiration date
31/12/9999
IT Number
07.16.2.
Domain
Human medicine
Field of application
Zytostatikum

Package details

Description (FR)
FULVESTRANT Sandoz 250 mg/5ml i.m. 2 ser pré 5 ml
Description (DE)
FULVESTRANT Sandoz 250 mg/5ml i.m. 2 Fertspr 5 ml
Market launch
23/10/2015
Narcotic (BTM)
No

Original drug

Faslodex, Injektionslösung
GTIN: 7680567780121
CHF 379.80
View original

Other package sizes (1)

FULVESTRANT Sandoz 250 mg/5ml i.m. ser pré 5 ml
None None
GTIN: 7680656510011
Not in V1
Buy us a coffee Explore the data